Regulation of platinum-compound cytotoxicity by the c-Jun N-terminal kinase and c-Jun signaling pathway in small-cell lung cancer cells

Molecular Pharmacology

Volumn 62, Issue 3, 2002, Pages 689-697

  Levresse, Valerie ^a   Marek, Lindsay ^a   Blumberg, Deborah ^a   Heasley, Lynn E ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MITOGEN ACTIVATED PROTEIN KINASE; PLATINUM DERIVATIVE; PROTEIN C JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TRANSPLATIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA MICROARRAY; DNA REPAIR; DRUG ACCUMULATION; DRUG SENSITIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME PHOSPHORYLATION; GENE IDENTIFICATION; GENE OVEREXPRESSION; GENETIC CODE; GLUTATHIONE METABOLISM; HYPOTHESIS; LUNG SMALL CELL CANCER; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

CARCINOMA, SMALL CELL; CELL SURVIVAL; CISPLATIN; ENZYME ACTIVATION; GENE EXPRESSION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; KINETICS; LUNG NEOPLASMS; MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; PLATINUM COMPOUNDS; SIGNAL TRANSDUCTION; TRANSFECTION;

EID: 0036765750     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.62.3.689     Document Type: Article

References (40)

1. Adams TE, Epa VC, Garrett TP, and Ward CW (2000) Structure and function of the type 1 insulin-like growth factor receptor. Cell Mol Life Sci 57:1050-1093.
2. Beekman A, Helfrich B, Bunn PA Jr, and Heasley LE (1998) Expression of catalytically-inactive phospholipase Cβ disrupts phospholipase Cβ and mitogen-activated protein kinase signaling and inhibits small cell lung cancer growth. Cancer Res 58:910-913.
3. Bunn PA Jr and Carney DN (1997) Overview of chemotherapy for small cell lung cancer. Semin Oncol 24:69-74.
4. 2-terminal kinaseregulation of the apoptotic response of small cell lung cancer cells to ultraviolet radiation. J Biol Chem 272:10110-10116.
5. Carboni L, Carletti R, Tacconi S, Corti C, and Ferraguti F (1998) Differential expression of SAPK isoforms in the rat brain. An in situ hybridisation study in the adult rat brain and during post-natal development. Brain Res Mol Brains Res 60:57-68.
6. Carmichael J, DeGraff WG, Gamson J, Russo D, Gazdar AF, Levitt ML, Minna JD, and Mitchell JB (1989) Radiation sensitivity of human lung cancer cell lines. Eur J Cancer Clin Oncol 25:527-534.
7. Carney DN, Mitchell JR, and Kinsella TJ (1983) In vitro radiation and chemotherapy sensitivity of established cell lines of human small cell lung cancer and its large cell morphological variants. Cancer Res 43:2806-2811.
8. Cole SP, Pinkoski MJ, Bhardwaj G, and Dealey RG (1992) Elevated expression of annexin II (lipocortin II, p36) in a multidrug resistant small cell lung cancer cell line. Br J Cancer 65:498-502.
9. Crul M, Schellens JHM, Beijnen dH, and Maliepaard M (1997) Cisplatin resistance and DNA repair. Cancer Treat Rev 23:341-366.
10. Delmastro DA, Li V, Vaisman A, Solle M, and Charney SG (1997) DNA damage inducible-gene expression following platinum treatment in human ovarian carcinoma cell lines. Cancer Chemother Pharmacol 39:245-253.
11. Dreskin SC, Thomas GW, Dale SN, and Heasley LE (2001) Isoforms of Jun kinase are differentially expressed and activated in human monocyte/macrophage (THP-1) cells. J Immunol 166:5646-5653.
12. Giachino C, Lantelme E, Lanzetti L, Saccone S, Bella Valle G, and Migone N (1997) A novel SH3-containing human gene family preferentially expressed in the central nervous system. Genomics 41:427-434.
13. Hazzalin CA and Mahadevan LC (2002) MAPK-regulated transcription: a continuously variable gene switch? Nature Rev 3:30-40.
14. Ip YT and Davis RJ (1998) Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 10:205-219.
15. Jordan P and Carmo-Fonseca M (2000) Molecular mechanisms involved in cisplatin cytotoxicity. Cell Mol Life Sci 57:1229-1235.
16. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, and Flavell RA (1999) The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 22:667-676.
17. Kyriakis J and Avruch J (1996) Sounding the alarm: Protein kinase cascades activated by stress and inflammation. J Biol Chem 271:24313-24316.
18. Kyriakis JM, Woodgett JR, and Avruch J (1995) The stress-activate protein kinases: a novel ERK subfamily responsive to cellular stress and inflammatory cytokines. Ann NY Acad Sci 766:303-319.
19. Levresse V, Moritz S, Renier A, Kheuang L, Galateau-Salle F, Mège JP, Piedbois P, Salmons B, Guenzburg W, and Jaurand MC (1998) Effect of simian virus large T antigen expression on cell cycle control and apoptosis in rat pleural mesothelial cells exposed to DNA damaging agents. Oncogene 16:1041-1053.
20. Li Q, Gardner K, Zhang L, Tsang B, Bostick-Bruton F, and Reed E (1998) Cisplatin induction of ERCC1 mRNA expression in A2780/cP70 human ovarian cancer cells. J Biol Chem 36:23419-23425.
21. Lippert B (1996) Trans-diammineplatinum (II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic adds. Met Ions Biol Syst 33:105-141.
22. Madsen P, Anant S, Rasmussen HH, Gromov P, Vorum H, Dumanski JP, Tommerup N, Collins JE, Wright CL, Dunham I, et al. (1999) Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J Invest Dermatol 113:162-169.
23. Martin-Satue M and Blanco J (1999) Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg Oncol 72:18-23.
24. Miller AD and Rosman GJ (1989) Improved retroviral vectors for gene transfer and expression. Biotechniques 7:980-990.
25. Nauert JB, Klauck TM, Langeberg LK, and Scott JD (1997) Gravin, an autoantigen recognized by sero from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol 7:52-62.
26. Persons DL, Yazlovitskaya EM, Cul W, and Pelling JC (1999) Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signed-regulated kinase activity increases sensitivity to cisplatin. Clin Cancer Res 5:1007-1014.
27. Potapova O, Basu S, Mercola D, and Holbrook NJ (2901) Protective role for c-Jun in the cellular response to DNA damage. J Biol Chem 276:28546-28553.
28. Potapova O, Haghighi A, Bost F, Lin C, Birrer MJ, Gjerset R, and Mercola D (1997) The Jun kinase/stress-activated protein kinase pathway functions to regulate DNA repair and inhibition of the pathway sensitizes tumor cells to cisplatin. J Biol Chem 272:14041-14044.
29. Quinn KA, Treston AM, Unsworth EJ, Miller MJ, Vos M, Grimley C, Battey J, Mulshine JL, and Cuttitta F (1996) Insulin-like growth factor expression in human cancer cell lines. J Biol Chem 271:11477-11483.
30. Sabapathy K, Jochumm W, Hochedlinger K, Chang L, Karin M, and Wagner EF (1999) Detective neural tube morphogenesis and altered apoptosis in the absence of both JNK1 and JNK2. Mech Dev 89:115-124.
31. Sanchez-Perez I, Martinez-Gomariz M, Williams D, Keyse SM, and Perona R (2000) CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin. Oncogene 19:5142-5152.
32. Sanchez-Perez I, Murguia JR, and Perona R (1998) Cisplatin induces a persistent activation of JNK that is related to cell death. Oncogene 16:533-540.
33. Sanchez-Perez I and Perona R (1999) Lack of c-Jun activity increases survival to cisplatin. FEBS Lett 453:151-158.
34. Sinha P, Hutter G, Kottgen E, Dietel M, Schadendorf D, and Lage H (1998) Increased expression of annexin I and thioredoxin detected by two-dimensional gel electrophoresis of drug resistant human stomach cancer cells. J Biochem Biophys Methods 37:105-116.
35. Tournier C, Hess P, Yang DD, Xu J, Turner TK, Nimnual A, Bar-Sagi D, Jones SN, Flavell RA, and Davis RJ (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science (Wash DC) 288:870-874.
36. Wallner BP, Mattaliano RJ, Hession C, Cate RL, Tizard R, Sinclair LK, Foeller C, Chow EP, Browing JL, Ramachandran KL, et al. (1986) Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity. Nature (Lond) 320:77-81.
37. Whitmarsh AJ and Davis RJ (2000) Regulation of transcription factor function by phosphorylation. Cell Mol Life Sci 57:1172-1183.
38. Wojtaszek PA, Heasley LE, Siriwardana G, and Berl T (1998) Dominant negative cJun N-terminal kinase 2 sensitizes renal inner medullary collecting duct cells to hypertonicity-induced lethality independent of organic osmolyte transport. J Biol Chem 273:800-804.
39. Yamada T, Endo R, Gotoh M, and Hirohashi S (1997) Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc Natl Acad Sci USA 94:14718-14718.
40. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Lin F-F, and Woodgett JR (1996) The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 6:606-613.